Pharmacogenomics

Pharmacogenomic testing, matched to what the patient is actually taking.

Not every patient on a psychiatric or cardiovascular medication needs a PGx panel. ScreenMyGene reads the active medication list, matches it against established CPIC drug-gene interactions, and only surfaces a panel when a real, documented interaction risk exists.

How it works for pharmacogenomics specifically

1. Medication list extraction — Active medications are pulled from the chart, including dose and indication where documented.

2. CPIC matching — Each medication is checked against CPIC drug-gene pairs. A panel only qualifies when there's a real interaction to evaluate.

3. Multi-gene panel logic — When multiple CPIC-relevant medications are present, ScreenMyGene surfaces the full panel that covers them.

4. ICD-10 and coverage check — The recommendation is anchored to a documented, matching diagnosis code and checked against Medicare LCD/NCD coverage policy.

What this catches that manual review often misses

• Polypharmacy patients on multiple CPIC-relevant drugs, where the qualifying panel spans more genes than a clinician would think to order manually
• Patients where a medication change has occurred since the last chart review
• Cases where a single-gene test would have been ordered, but the full CPIC-relevant panel is actually indicated

Who this is for

• Ordering clinicians who want the right panel surfaced without memorizing the CPIC drug-gene table
• Genetic counselors and medical directors who need a consistent, auditable basis for why a panel was recommended
• Molecular labs triaging inbound PGx orders and reducing avoidable denials tied to weak documentation